がん化学療法によるB型肝炎ウイルス再活性化予防に関する医師・臨床検査技師・薬剤師による共同薬物治療管理と情報共有

書誌事項

タイトル別名
  • Information Sharing in Collaborative Drug Therapy Management Service by Doctors, Medical Technologists and Pharmacists for Prevention of Hepatitis B Virus Reactivation Caused by Cancer Chemotherapy

この論文をさがす

抄録

<p>Recently, the high mortality rate resulting from the reactivation of hepatitis B virus (HBV) through the use of immunosuppressive therapy or chemotherapy for fulminant hepatitis patients has been recognized as one of the most critical medical issues.</p><p>On May 19, 2014, we started a collaborative drug therapy management (HBV-CDTM) project to establish a preventive procedure that can be used to avoid HBV reactivation. Before starting the project, the project protocol developed by the commission of chemotherapy was approved by the Director of Iwakuni Clinical Center. We decided to manage the HBV screening demonstrated in the hepatitis B treatment guidelines in collaboration with pharmacists, doctors and medical technologists. To fill in clinical records when conducting HBV-CDTM, we used the “eXChart” of the electronic clinical record system “HOPE/EGMAIN-GX” to simplify tasks, information sharing among medical staff members with different duties and collection of electronic clinical data.</p><p>From May 19, 2014 to January 31, 2015, we applied HBV-CDTM to 211 patients in total, and found three patients (1.4%) were hepatitis B surface antigen (HBsAg)-positive, and 75 patients (35.5%) were hepatitis B core antibody positive and/or hepatitis B surface antibody-positive despite being HBsAg-negative. We extracted 78 high-risk patients of HBV reactivation through HBV-CDTM. In addition, the operation rate of HBV screening examination after the introduction of HBV-CDTM rose to 98.6% from that of 3.2% before introduction.</p><p>Through the HBV-CDTM project, we concluded that the introduction of HBV-CDTM enabled reduction of doctors' loads and enhanced the preventive procedure against HBV reactivation.</p>

収録刊行物

  • 医療薬学

    医療薬学 41 (10), 677-686, 2015

    一般社団法人日本医療薬学会

被引用文献 (6)*注記

もっと見る

参考文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ